Episode 52 -The Collective Lie in Ketamine Therapy (Part 1): Why the Experience Isn't the Treatment

Episode 52 -The Collective Lie in Ketamine Therapy (Part 1): Why the Experience Isn't the Treatment

Author: Ketamine StartUp March 16, 2026 Duration: 35:52
Anesthesia provider Charles Miller presents controversial research arguing that ketamine therapy's emphasis on experiences actually reduces success rates. He explains the NMDA-glutamate-BDNF pathway, critiques popular research methodologies, and makes the case for focusing on post-treatment neuroplasticity rather than psychedelic insights during treatment.

Hosted by Sam and Kim Ko, two board-certified physicians who actually run a ketamine therapy practice, The Ketamine StartUp Podcast digs into the real, unvarnished work of building this kind of medical business from the ground up. It’s a conversation for clinicians and entrepreneurs who are past the theory and need practical, actionable advice. You’ll hear us break down the complexities of patient care protocols alongside the fundamentals of marketing, operations, and financial planning, all through the lens of our own successes and stumbles. Each episode brings in voices from our network-fellow practitioners, legal experts, and business mentors-to explore the full spectrum of running a compliant and compassionate practice. This isn't about hype; it's a detailed roadmap. Tuning into this podcast means getting a candid look at the intersection of modern medicine and entrepreneurship, where clinical expertise meets the realities of building a sustainable service. We share the lessons that aren’t in textbooks, from navigating regulatory gray areas to building a team that aligns with your clinical values, because launching and growing this work involves much more than medicine alone. Join us as we cover the entire journey, one frank discussion at a time.
Author: Language: English Episodes: 54

The Ketamine StartUp Podcast
Podcast Episodes